IMAX Closes $250 Million Convertible Senior Notes Offering
Reuters
Nov 07
IMAX Closes $250 Million Convertible Senior Notes Offering
IMAX Corporation has announced the closing of its private offering of $250 million aggregate principal amount of 0.75% convertible senior notes due 2030. The notes were sold to qualified institutional buyers and carry an interest rate of 0.75% per annum. The initial conversion rate is 23.5743 common shares per $1,000 principal amount of notes, with an initial conversion price of approximately $42.42 per common share-representing a 30% premium over the last reported sale price on November 3, 2025. The capped call cap price is set at $57.10, a 75% premium over the same date's closing price. The net proceeds of approximately $241.1 million were used, together with cash on hand and borrowings under IMAX's credit facility, to repurchase $229.7 million of the company's outstanding 0.500% Convertible Senior Notes due 2026 and to purchase capped call transactions. No URL for the full prospectus is included in the document.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IMAX Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106350799) on November 06, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.